PAMS
CPRX

Pictet Asset Management (Switzerland)’s Catalyst Pharmaceutical CPRX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$169K Hold
12,538
– – ﹤0.01% 1768
2023
Q1 		$208K Hold
12,538
– – ﹤0.01% 1712
2022
Q4 		$233K Buy
+12,538
New +$193K ﹤0.01% 1642
2021
Q4 		– Sell
-12,800
Closed -$68K – 1747
2021
Q3 		$68K Buy
+12,800
New +$70K ﹤0.01% 1715

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s CPRX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2023 at 12,538 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #1768.

Pictet Asset Management (Switzerland) first reported a position in CPRX in Q3 2021 and has held it in 4 quarters since. The position peaked at $233K in Q4 2022. 248 funds tracked by Wall St. Rank hold CPRX as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 12,538 shares of Catalyst Pharmaceutical worth $169K as of Q2 2023.
  • Pictet Asset Management (Switzerland) left its Catalyst Pharmaceutical share count unchanged in Q2 2023.
  • Catalyst Pharmaceutical made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1768 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Catalyst Pharmaceutical in Q3 2021 and has held it in 4 quarters since.
  • Pictet Asset Management (Switzerland)'s Catalyst Pharmaceutical position peaked at $233K in Q4 2022.
  • 248 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.